ST elevation myocardial infarction lipid management: Difference between revisions
Jump to navigation
Jump to search
/* Lipid Management (DO NOT EDIT){{cite journal |author=O'Gara PT, Kushner FG, Ascheim DD, et al. |title=2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardi... |
No edit summary |
||
| (7 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ST elevation myocardial infarction}} | {{ST elevation myocardial infarction}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{YK}} | ||
==2013 | ==2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary(DO NOT EDIT)<ref name="pmid23256913">{{cite journal| author=American College of Emergency Physicians. Society for Cardiovascular Angiography and Interventions. O'Gara PT, Kushner FG, Ascheim DD, Casey DE et al.| title=2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. | journal=J Am Coll Cardiol | year= 2013 | volume= 61 | issue= 4 | pages= 485-510 | pmid=23256913 | doi=10.1016/j.jacc.2012.11.018 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23256913 }} </ref>== | ||
===Lipid Management (DO NOT EDIT)<ref name="pmid23256913">{{cite journal| author=American College of Emergency Physicians. Society for Cardiovascular Angiography and Interventions. O'Gara PT, Kushner FG, Ascheim DD, Casey DE et al.| title=2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. | journal=J Am Coll Cardiol | year= 2013 | volume= 61 | issue= 4 | pages= 485-510 | pmid=23256913 | doi=10.1016/j.jacc.2012.11.018 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23256913 }} </ref>=== | |||
{|class="wikitable" | {|class="wikitable" | ||
| Line 12: | Line 11: | ||
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | | colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' High-intensity statin therapy should be initiated or continued in all patients with STEMI and no contraindications to its use.<ref name="pmid16875966">{{cite journal |author=Cannon CP, Steinberg BA, Murphy SA, Mega JL, Braunwald E |title=Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy |journal=J. Am. Coll. Cardiol. |volume=48 |issue=3 |pages=438–45 |year=2006 |month=August |pmid=16875966 |doi=10.1016/j.jacc.2006.04.070 |url=}}</ref><ref name="pmid21067804">{{cite journal |author=Baigent C, Blackwell L, Emberson J, ''et al.'' |title=Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials |journal=Lancet |volume=376 |issue=9753 |pages=1670–81 |year=2010 |month=November |pmid=21067804 |pmc=2988224 |doi=10.1016/S0140-6736(10)61350-5 |url=}}</ref><ref name="pmid15007110">{{cite journal |author=Cannon CP, Braunwald E, McCabe CH, ''et al.'' |title=Intensive versus moderate lipid lowering with statins after acute coronary syndromes |journal=N. Engl. J. Med. |volume=350 |issue=15 |pages=1495–504 |year=2004 |month=April |pmid=15007110 |doi=10.1056/NEJMoa040583 |url=}}</ref>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' High-intensity [[statin]] therapy should be initiated or continued in all patients with STEMI and no contraindications to its use.<ref name="pmid16875966">{{cite journal |author=Cannon CP, Steinberg BA, Murphy SA, Mega JL, Braunwald E |title=Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy |journal=J. Am. Coll. Cardiol. |volume=48 |issue=3 |pages=438–45 |year=2006 |month=August |pmid=16875966 |doi=10.1016/j.jacc.2006.04.070 |url=}}</ref><ref name="pmid21067804">{{cite journal |author=Baigent C, Blackwell L, Emberson J, ''et al.'' |title=Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials |journal=Lancet |volume=376 |issue=9753 |pages=1670–81 |year=2010 |month=November |pmid=21067804 |pmc=2988224 |doi=10.1016/S0140-6736(10)61350-5 |url=}}</ref><ref name="pmid15007110">{{cite journal |author=Cannon CP, Braunwald E, McCabe CH, ''et al.'' |title=Intensive versus moderate lipid lowering with statins after acute coronary syndromes |journal=N. Engl. J. Med. |volume=350 |issue=15 |pages=1495–504 |year=2004 |month=April |pmid=15007110 |doi=10.1056/NEJMoa040583 |url=}}</ref> ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | ||
|} | |} | ||
== | {|class="wikitable" | ||
|- | |||
| colspan="1" style="text-align:center; background:LemonChiffon"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]] | |||
|- | |||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.''' It is reasonable to obtain a fasting [[lipid profile]] in patients with STEMI, preferably within 24 hours of presentation. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | |||
|} | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Disease]] | |||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Ischemic heart diseases]] | |||
[[Category:Intensive care medicine]] | |||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Mature chapter]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Latest revision as of 16:49, 1 November 2016
|
ST Elevation Myocardial Infarction Microchapters |
|
Differentiating ST elevation myocardial infarction from other Diseases |
|
Diagnosis |
|
Treatment |
|
|
Case Studies |
|
ST elevation myocardial infarction lipid management On the Web |
|
ST elevation myocardial infarction lipid management in the news |
|
Blogs on ST elevation myocardial infarction lipid management |
|
Directions to Hospitals Treating ST elevation myocardial infarction |
|
Risk calculators and risk factors for ST elevation myocardial infarction lipid management |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[2]
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary(DO NOT EDIT)[1]
Lipid Management (DO NOT EDIT)[1]
| Class I |
| "1. High-intensity statin therapy should be initiated or continued in all patients with STEMI and no contraindications to its use.[2][3][4] (Level of Evidence: B)" |
| Class IIa |
| "1. It is reasonable to obtain a fasting lipid profile in patients with STEMI, preferably within 24 hours of presentation. (Level of Evidence: C)" |
References
- ↑ 1.0 1.1 American College of Emergency Physicians. Society for Cardiovascular Angiography and Interventions. O'Gara PT, Kushner FG, Ascheim DD, Casey DE; et al. (2013). "2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". J Am Coll Cardiol. 61 (4): 485–510. doi:10.1016/j.jacc.2012.11.018. PMID 23256913.
- ↑ Cannon CP, Steinberg BA, Murphy SA, Mega JL, Braunwald E (2006). "Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy". J. Am. Coll. Cardiol. 48 (3): 438–45. doi:10.1016/j.jacc.2006.04.070. PMID 16875966. Unknown parameter
|month=ignored (help) - ↑ Baigent C, Blackwell L, Emberson J; et al. (2010). "Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials". Lancet. 376 (9753): 1670–81. doi:10.1016/S0140-6736(10)61350-5. PMC 2988224. PMID 21067804. Unknown parameter
|month=ignored (help) - ↑ Cannon CP, Braunwald E, McCabe CH; et al. (2004). "Intensive versus moderate lipid lowering with statins after acute coronary syndromes". N. Engl. J. Med. 350 (15): 1495–504. doi:10.1056/NEJMoa040583. PMID 15007110. Unknown parameter
|month=ignored (help)